GlobalImpactPartner_transparent

SCRS and its Leadership Council are committed to building partnership opportunities between their members and sponsors, CROs and professional providers. The Society has developed the Global Impact Partnership (GIP), available to sponsors, CROs, and professional providers, to facilitate a unique opportunity to engage with SCRS and its members. An executive from the GIP company will have a seat on the GIP Board. The GIP board will interface with the SCRS’ Leadership Council to help set strategic initiatives for the Society.

Learn more about SCRS’ Corporate Sponsorship opportunities.

4G Clinical is a leader in randomization and trial supply management (RTSM) for the global life sciences industry, offering the only fully cloud-based, 100% configurable and flexible solution utilizing natural language processing (NLP) and integrated supply forecasting. 4G Clinical is headquartered in the Boston Biotech corridor of Wellesley, MA, with offices in Europe and Asia. For more information, visit www.4gclinical.com.

AbbVie is a global, research-driven biopharmaceutical company committed to developing innovative advanced therapies for some of the world’s most complex and critical conditions. The company’s mission is to use its expertise, dedicated people and unique approach to improve treatments and advance health solutions for people around the world. www.abbvie.com

Accelerated Enrollment Solutions (AES) is the new standard in clinical trial productivity. Our innovative and integrated site and patient services secure the success of clinical trials by providing enrollment, timing, and budget certainty. AES offers sponsors and contract research organizations best-in-class site conduct and patient access solutions, which include engaging, recruiting and retaining patients in clinical studies via a global network of dedicated research sites.

Advarra is the premier provider of global research compliance services, including IRB, IBC, consulting, and research technology solutions. Clinical trial sponsors and CROs recognize Advarra as the largest integrated provider of IRB services with the greatest institutional reach among health systems, cancer centers, academic medical centers, and investigators. Forte, now part of Advarra, is the industry’s leading provider of standards-based clinical research technology solutions, incorporating a fully integrated suite for clinical trial management, clinical data management, and research administration, including OnCore CTMS. Advarra accelerates study startup and supports better decision-making by providing robust regulatory expertise and insightful data analytics. Advarra also provides opportunities for continuous learning and collaboration, such as the Onsemble Community and conferences, to support best practices and make research altogether better.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives. Amgen has grown to be the world’s largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. www.amgen.com

AstraZeneca is a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of cardiovascular, metabolic, respiratory, inflammation, autoimmune, oncology, infection, and neuroscience diseases. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. www.astrazeneca.com

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In 2016, the Group employed around 115,200 people. For more information, go to www.bayer.com.

Clinical Conductor is the industry’s first collaborative and configurable CTMS for research managing or executing clinical trials. The system and provides users with the specific features and functionality they need to recruit effectively, improve overall patient visit satisfaction maintain billing and research compliance and maximize profitability. Used by over 1,800 organizations around the world, Clinical Conductor provides organizations with the tools they need to continue to raise the bar in clinical research. www.bio-optronics.com

Boehringer Ingelheim is committed to improving lives and providing valuable services and support to patients and their families. Our employees create and engage in programs that strengthen our communities. Since its founding in 1885, the company has remained family-owned and today creates value through innovation for three business areas including human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. www.boehringer-ingelheim.com

Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines to patients with serious diseases. Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B and hepatitis C, HIV/AIDS and, rheumatoid arthritis. At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development. www.bms.com

Clincierge® improves clinical trial performance by reducing barriers to participation, enhancing enrollment, and minimizing drop-outs. Our expertise and services lessen burdens on patients, caregivers, and sites while improving communications and coordination. We help keep studies on schedule, on budget, and data quality high, while making patient concerns a priority. http://clincierge.com/

Clinithink’s CLiX ENRICH solution delivers exciting new insight for life science and healthcare by using AI to extract the rich, unstructured data from a patient’s electronic medical record. Clinithink’s Clinical Natural Language Processing technology is currently being used all over the globe to fast forward drug development and enhance patient care. For further information visit clinithink.com.

Cognizant partners with biopharmaceutical and med-tech companies to develop strategies and apply solutions to healthcare challenges across the value chain. Our platforms and services are digitizing interactions between sponsors, investigators, patients, and regulators across every phase, helping the industry subtract time from clinical development and add it to patient lives. To learn more, visit www.cognizant.com.

Complion’s industry leading eRegulatory document and workflow management platform improves efficiency, compliance and transparency for research sites and sponsors. The sponsor-approved, turn-key platform stores, organizes and routes all of the regulatory documentation involved in a clinical trial.  On average, Complion’s customers save over $6,000 per trial because staff members spend less time chasing down paper and physical materials, along with storage space, are no longer needed. Complion has garnered overwhelming industry support and has been accessed by more Sponsors and CROs than any other eRegulatory platform. Thousands of clinical trials have been managed and stored in Complion.

Covance, the drug development business of Laboratory Corporation of America® Holdings (LabCorp®), is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®. www.covance.com

A full service global Contract Research Organization (CRO) specializing in clinical trials and observational studies across a variety of therapeutic areas and rare diseases in both compound and medical device. Our purpose is to do our part to ensure products that can truly make a difference are given the best chance to do so. Our promise is to provide a CRO experience you’ll want to come back to. www.cpiglobalcro.com

CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative therapies. The company offers the broadest range of products in the industry for treating coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders. CSL Behring’s products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

The company operates one of the world’s largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL; USOTC:CLLY), headquartered in Melbourne, Australia, employs nearly 20,000 people, providing life-saving therapies to people in more than 60 countries. For more information visit www.cslbehring.comand follow us on www.Twitter.com/CSLBehring.

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, is a specialized biopharmaceutical company dedicated to developing therapies with groundbreaking potential. The company has strong market positions in neurology, endocrinology, and reproductive health. EMD Serono has an enduring commitment to solve the unsolvable, with state-of-the-art science dedicated to developing new therapies in our core focus areas of neurology, oncology, immuno-oncology, and immunology. The company’s US footprint continues to grow, with approximately 1,000 employees around the country and fully integrated commercial, clinical, and research operations in the company’s home state of Massachusetts. www.emdgroup.com

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enabling people to do more, feel better, and live longer. www.gsk.com

GlobalCare Clinical Trials, LLC is the leading global provider of ambulant healthcare services for clinical trials. GlobalCare provides innovative, GCP-compliant services for biopharmaceutical companies by conducting selected study visits at locations convenient and comfortable for the patient when travel to the investigator site is not practical. GlobalCare’s traveling clinicians provide patients with a convenient way to participate in trials regardless of study duration, frequency of visits, their disease state or distance to the study site. Additionally, GlobalCare’s patient-centric approach helps to accelerate patient recruitment and improve study patient compliance and retention. globalcarect.com

Greenphire’s technology solutions take a patient-centric and site-centric approach to driving data integrity and data completeness for sponsor, CRO, and site clients. Greenphire’s patient payment and communication system, the ClinCard System, is designed to improve the clinical experience for patients and sites, drive positive patient behavior, and increase patient retention and compliance. The ClinCard System also significantly reduces site and study team administration associated with patient payments and communication, enabling coordinators and study managers to focus time on ensuring data cleanliness and completeness. For more information, please visit www.greenphire.com.

IQVIA (NYSE:IQV) is a leading global provider of information, innovative technology solutions and contract research services dedicated to using analytics and science to help healthcare stakeholders find better solutions for their patients. Solutions are powered by the IQVIA CORE™, which combines big data, advanced technology, analytics and extensive industry knowledge. Formed through the merger of IMS Health and Quintiles, IQVIA has approximately 55,000 employees worldwide. Learn more at iqvia.com.

At Janssen, we are dedicated to addressing some of the most important unmet medical needs in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. Janssen-Cilag International NV is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. www.janssen.com

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and newsroom.lilly.com/social-channels.

Medidata is the leading global provider of cloud-based solutions for clinical research in life sciences, transforming clinical development through its advanced applications and intelligent data analytics. The Medidata Clinical Cloud™ brings new levels of productivity and quality to the clinical testing of promising medical treatments, from study design and planning through execution, management and reporting. www.mdsol.com

Medpace is a global full-service clinical research organization (CRO) providing Phase I-IV core development services for drug, biologic, and device programs. Medpace has strong experience supporting development programs across therapeutic areas including oncology, cardiovascular, metabolic/diabetes, infectious diseases and vaccines, neuroscience, regenerative medicine, gastrointestinal diseases, pediatrics, and orphan disease. From feasibility, research site compatibility, safety, and logistics, Medpace brings efficiencies and operational excellence to both drug and device development programs. www.medpace.com

Merck & Co., Inc., Whitehouse Station, NJ, USA is a global healthcare leader working to help the world be well. Through our prescription medicines, vaccines, biologic therapies, and consumer care and animal health products, we work with customers and operate in more than 140 countries to deliver innovative health solutions. We also demonstrate our commitment to increasing access to healthcare through far-reaching policies, programs and partnerships. For more information, visit www.merck.com and connect with us on TwitterFacebook, and YouTube.

Oracle Health Sciences breaks down barriers and opens new pathways to unify people and processes to bring new drugs to market faster. As a leader in Life Sciences technology, Oracle Health Sciences is trusted by 29 of the top 30 pharma, 10 of the top 10 biotech and 10 of the top 10 CROs for managing clinical trials and pharmacovigilance around the globe. www.oracle.com/lifesciences.

Parexel is focused on supporting the development of innovative new therapies to improve patient health. We do this through a suite of services that help life science and biopharmaceutical customers across the globe transform scientific discoveries into new treatments for patients. From clinical trials to regulatory and consulting services to commercial and market access, our therapeutic, technical and functional ability is underpinned by a deep conviction in what we do. For more information, visit our website and follow us on LinkedIn and Twitter. Parexel is a registered trademark of Parexel International Corporation. All other trademarks are the property of their respective owners.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. We collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us. www.pfizer.com

PPD is a leading global contract research organization providing drug discovery, development, lifecycle management, and laboratory services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic, and government organizations. With offices in 46 countries and more than 13,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a commitment to quality to help clients and partners accelerate the delivery of safe and effective therapeutics and maximize the returns on their R&D investments.
www.ppdi.com

PRA Health Sciences delivers innovative drug development solutions that improve patients’ lives. Our people are passionate about clinical research, working tirelessly to provide quality results. We offer exceptional experience across all phases and therapeutic areas and a broad spectrum of solutions, ranging from full-service clinical development to a pioneering embedded model.

With 16,000+ employees covering 90+ countries, we bolster an impressive global presence with keen local insights. Our project teams harness their understanding of local regulations, standards of care and cultural customs to effectively align our approaches with each study’s unique goals.

At PRA, we love what do because we are making a difference in the lives of patients and their family members worldwide. Over the years, we have contributed to the development of numerous drugs now available to countless patients. From our scientific and medical experts to therapeutically aligned project managers and monitors, we provide the commitment and expertise needed for today’s complex study.  www.prahs.com

PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and is known to be highly selective about the work that they pursue. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its customers and its employees.

RealTime Software Solution is a global leader in SAAS-based Clinical Trials Management Systems for Sites, Sponsors, and CROs. RealTime is also the only CTMS vendor that can offer a complete suite of solutions into a seamless platform, SOMS (Site Operations Management System). SOMS includes the industry-leading CTMSSitePAYTEXTeDOCS, and eSOURCE which is accessible through an easy-to-use MobileAPP. RealTime also has the most advanced multi-site and site network enterprise systems available anywhere.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. For more information, please visit www.roche.com.

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). www.sanofi.us

StudyKIK is the leading Website connecting patients to clinical trials through thousands of social media communities across Instagram, Snapchat, Facebook, Twitter, and Pinterest. Live in 24 hours, sites receive 30-200* patients every 30 days. Sites can maximize enrollment with Tools including: StudyKIK Patient Messaging Suite (Instant Text Messaging, Appointment Reminders, & Text Blasting).

Syneos Health is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry-leading companies – INC Research and inVentiv Health – we bring together more than 21,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. To learn more about how we are shortening the distance from lab to life visit SyneosHealth.com.

Total Clinical Trial Management (TCTM), is a contract research organization based in Dallas, Texas. TCTM has a unique perspective on emphasizing the relationship with the clinical research site as a primary driver for successful clinical trial completion. TCTM has a wide range of therapeutic expertise with recent areas of focus including pain, orthopedic injury, GI, dermatology, cosmetics, over-the-counter (OTC) and generics studies.

Trifecta is a global leader & trusted partner with deep experience in clinical trial technology solutions for leading pharmaceutical, biotech and clinical research organizations. Trifecta offers clinical trial solutions including: Online/On-Demand Investigator Training, Live & Web-Based Investigator Meetings, Safety Letter Delivery and Document Exchange. To learn more, please visit www.trifectaclinical.com.

TrialScout™ provides high-quality Clinical Research Sites with a powerful new patient engagement and retention platform that builds their brand with patients and sponsors. TrialScout supports your clinical trials with its first-ever patient experience ratings and reviews, generating unique monthly analytics to optimize your Site operations. TrialScout helps patients find your clinical trials and supports them in choosing your Site, while keeping them engaged to reduce dropout. For more information visit www.TrialScout.com.

Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to streamlining the end-to-end clinical trial process, Veeva offers the industry’s first cloud platform that combines EDC, eSource, CTMS, eTMF, and study start-up to unify clinical data management and clinical operations. Veeva has more than 500 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. www.veeva.com

Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, Mass. and headquartered in Boston’s Innovation District, Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. In addition to our clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. Vertex collaborates with some of the world’s largest pharmaceutical companies, leading nonprofit disease foundations and many of the world’s best-known academic institutions. www.vrtx.com

VirTrial has a stable, long-standing virtual care platform customized for clinical trial use with both patient and site needs in mind. VirTrial is transforming the use of telemedicine in the clinical research industry by offering a patient management program that combines video, text, and email for clinical trial sites to easily and conveniently address specific patient and/or study needs in a secure environment. The platform can be used on any device and at any site. The company vision is to replace 25-40 percent of standard clinical trial visits with virtual visits to create hybrid studies. This model is best suited for Phase III and IV studies, rare diseases and to replace traditional telephone calls within a protocol.

VirTrial enables higher performance by clinical trial sites, greater accessibility to trials for patients, and improved outcomes for pharmaceutical companies. Working together we can bring better medications to market more quickly. https://www.VirTrial.com.